Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    WS04 - IASLC/IMIG Workshop - The Future of Mesothelioma Treatment

    • 08:00 - 11:00
    • 8/06/2022
    • Location: Lehar 4
    • Not for CME Credit
    • Type: Workshop
    • Track: N/A
    • +

      WS04.12 - Panel - Everything You Wanted to Know About Mesothelioma but Were Afraid to Ask

      10:15 - 10:15  |  Presenter: Paul Baas

      • Abstract

      Loading...

  • +

    IBS06 - Which Therapy for Which MPM Patient? (Ticketed Session) (In-person Access Only)

    • 07:30 - 08:15
    • 8/07/2022
    • Location: Lehar 4
    • IASLC CME Accredited
    • Type: Interactive Breakfast Session
    • Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies
    • +

      Session Moderator

      08:02 - 08:15  |  Presenter: Paul Baas

      • Abstract

      Loading...

    • +

      IBS06.01 - Session Introduction

      07:30 - 07:32  |  Presenter: Paul Baas

      • Abstract

      Loading...

  • +

    OA04 - Mesothelioma Under the Looking Glass

    • 14:30 - 15:30
    • 8/07/2022
    • Location: Hall C8
    • Not for CME Credit
    • Type: Oral
    • Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies
    • +

      OA04.06 - PEMbrolizumab Plus Lenvatinib In Second And Third Line Malignant Pleural MEsotheLiomA Patients: A Single Arm Phase II Study (PEMMELA)

      15:02 - 15:12  |  Presenter: Li-Anne Huaqing Douma

      • Abstract

      Loading...